Turnstone Biologics Corp.
TSBX · NASDAQ
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Market Cap | $8 | $9 | $11 | $13 |
| - Cash | $17 | $22 | $29 | $24 |
| + Debt | $0 | $1 | $1 | $2 |
| Enterprise Value | -$8 | -$12 | -$16 | -$10 |
| Revenue | $0 | $0 | $2 | $0 |
| % Growth | – | -100% | – | – |
| Gross Profit | $0 | -$0 | $1 | -$1 |
| % Margin | – | – | 50% | – |
| EBITDA | -$6 | -$12 | -$11 | -$18 |
| % Margin | – | – | -547.1% | – |
| Net Income | -$5 | -$12 | -$13 | -$17 |
| % Margin | – | – | -637.9% | – |
| EPS Diluted | -0.24 | -0.51 | -0.56 | -0.74 |
| % Growth | 52.9% | 8.9% | 24.3% | – |
| Operating Cash Flow | -$4 | -$7 | -$16 | -$17 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$4 | -$7 | -$16 | -$17 |